Key facts
- Notable investors include Firstgate (South Korea).
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Q'rious Biotech
- ·The full record, as it builds
Funding rounds
No funding rounds for Q'rious Biotech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Q'rious Biotech
Provider of antibiotic susceptibility diagnostic test, based in South Korea. The company is operating in Stealth mode.
- Sector
- Healthcare
- HQ
- Incheon, South Korea
- Founded
- 2023
- Ownership
- Privately Held (backing)
Q'rious Biotech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Q'rious Biotech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Q'rious Biotech in its N-PORT filings yet. We sweep new filings monthly.